Maravai Lifesciences Holdings, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -5.20M78.82M469.25M490.66M-138.38M-259.62M
Depreciation and Depletion 3.81M5.60M6.41M7.60M12.90M20.90M
Share-based Compensation 1.68M24.63M10.46M18.67M34.59M49.41M
Deferred Taxes -1.16M-5.46M46.90M42.32M754.94M0.01M
Gains from Investment Securities -0.69M-2.42M22.47M23.03M32.86M-2.00M
Cash from Operations 24.11M152.19M368.57M535.98M126.22M7.46M
Depreciation, Depletion & Amortization
Amortization of Goodwill 166.15M
Amortizatization of Intangibles 20.27M20.32M18.34M24.27M27.36M27.53M
Amortization of Deferred Charges 1.73M19.00M2.68M2.79M2.93M2.90M
Depreciation & Amortization (CF) 3.81M5.60M6.41M7.60M12.90M20.90M
Change in Working Capital
Change in Receivables 1.89M33.14M70.39M22.27M-84.39M-14.36M
Change in Inventory -0.11M19.10M21.57M-9.46M-0.65M-0.38M
Change in Account Payables 2.47M1.18M0.68M-1.58M5.28M0.72M
Change in Accured Expenses 3.50M17.78M-3.46M8.50M15.11M-22.75M
Other Working Capital Changes 1.98M77.22M-67.85M35.90M-15.98M-6.30M
Investing Activities
Capital Expenditures 17.15M25.41M14.85M17.09M65.55M29.66M
Sales of Property, Plant and Equipment 34.50M0.55M
Change in Intangibles 1.50M
Acquisitions 238.97M69.62M
Divestments 119.96M0.62M
Cash from Investing Activities -17.15M6.07M105.66M-267.61M-122.31M-24.32M
Financing Activities
Other financing activities 9.29M6.17M9.29M
Cash from Financing Activities -4.17M53.21M-159.05M-187.50M-61.09M-235.71M
Dividend Payments
Dividends Paid - Common 120.00M153.45M150.21M9.61M0.49M
Additional items
Exchange Rate Effect 0.03M0.02M-0.09M
Change in Cash 2.83M211.48M315.09M80.87M-57.18M-252.56M
Free Cash Flow 6.97M126.78M353.72M518.89M60.67M-22.19M
Net Cash Flow 2.80M211.47M315.18M80.87M-57.18M-252.56M